BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1765863)

  • 41. [Safety criteria in working with metallic beryllium].
    Petrin SV; Petrina LS; Pinaev VS
    Gig Sanit; 2004; (2):28-31. PubMed ID: 15141624
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Rationale for choice of safety criteria during accidents while working with metallic beryllium].
    Petrin SV; Petrina LS
    Gig Sanit; 2004; (4):65-7. PubMed ID: 15318622
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Berylliosis in the work environment: etiology and medical treatment].
    Sieradzki A; Andrzejak R; Sieradzka U
    Med Pr; 2002; 53(2):151-60. PubMed ID: 12116906
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comment on corporate strategy: beryllium, Brush Wellman, and NIOSH.
    Rodrigues E
    New Solut; 2007; 17(4):283-4. PubMed ID: 18184620
    [No Abstract]   [Full Text] [Related]  

  • 45. Beryllium: a paradigm for occupational lung disease and its prevention.
    Kreiss K
    Occup Environ Med; 2011 Nov; 68(11):787-8. PubMed ID: 21984591
    [No Abstract]   [Full Text] [Related]  

  • 46. Beryllium and lung disease.
    Meyer KC
    Chest; 1994 Sep; 106(3):942-6. PubMed ID: 8082384
    [No Abstract]   [Full Text] [Related]  

  • 47. [Chronic berylliosis].
    Müller-Quernheim J; Gaede KI; Prasse A; Zissel G
    Pneumologie; 2007 Feb; 61(2):109-16. PubMed ID: 17290317
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beryllium screening raises ethical issues.
    Marshall E
    Science; 1999 Jul; 285(5425):178-9. PubMed ID: 10428708
    [No Abstract]   [Full Text] [Related]  

  • 49. Beryllium-stimulated apoptosis in macrophage cell lines.
    Sawyer RT; Fadok VA; Kittle LA; Maier LA; Newman LS
    Toxicology; 2000 Aug; 149(2-3):129-42. PubMed ID: 10967410
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Beryllium disease: first case reported in Israel.
    Fireman E; Kramer MR; Kaufman N; Müller-Quernheim J; Lerman Y
    Isr Med Assoc J; 2001 Mar; 3(3):224-5. PubMed ID: 11303384
    [No Abstract]   [Full Text] [Related]  

  • 51. [Characteristics of the functional state of the lymphocytes in berylliosis studied by the blast transformation method].
    Shpakova AP; Ermakova NG
    Sov Med; 1979 Apr; (4):20-4. PubMed ID: 312533
    [No Abstract]   [Full Text] [Related]  

  • 52. Screening for chronic beryllium disease: one hurdle down, two to go.
    Cullen MR
    Am J Respir Crit Care Med; 2005 Jan; 171(1):3-4. PubMed ID: 15615889
    [No Abstract]   [Full Text] [Related]  

  • 53. Immunology of chronic beryllium disease.
    Samuel G; Maier LA
    Curr Opin Allergy Clin Immunol; 2008 Apr; 8(2):126-34. PubMed ID: 18317020
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of an abnormal beryllium lymphocyte proliferation test.
    Frome EL; Newman LS; Cragle DL; Colyer SP; Wambach PF
    Toxicology; 2003 Feb; 183(1-3):39-56. PubMed ID: 12504341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of in vitro and in vivo tests of hypersensitivity in beryllium workers.
    Price CD; Williams WJ; Pugh A; Joynson DH
    J Clin Pathol; 1977 Jan; 30(1):24-28. PubMed ID: 320228
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IL-4 fails to regulate in vitro beryllium-induced cytokines in berylliosis.
    Maier LA; Sawyer RT; Tinkle SS; Kittle LA; Barker EA; Balkissoon R; Rose C; Newman LS
    Eur Respir J; 2001 Mar; 17(3):403-15. PubMed ID: 11405518
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term efficacy of a program to prevent beryllium disease.
    Thomas CA; Deubner DC; Stanton ML; Kreiss K; Schuler CR
    Am J Ind Med; 2013 Jul; 56(7):733-41. PubMed ID: 23450749
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Normal blood lymphocyte blast transformation in berylliosis and silicosis patients].
    Shpakova AP; Sokolov VV
    Gig Tr Prof Zabol; 1976 Aug; (8):19-22. PubMed ID: 1010369
    [No Abstract]   [Full Text] [Related]  

  • 59. Screening for beryllium disease among construction trade workers at Department of Energy nuclear sites.
    Welch L; Ringen K; Bingham E; Dement J; Takaro T; McGowan W; Chen A; Quinn P
    Am J Ind Med; 2004 Sep; 46(3):207-18. PubMed ID: 15307119
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic beryllium disease prevention program. Office of Environment, Safety and Health, Department of Energy. Final rule.
    Fed Regist; 1999 Dec; 64(235):68854-914. PubMed ID: 11010683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.